Intratympanic dexamethasone as a symptomatic treatment for Ménière's disease.
about
Neuro-otology- some recent clinical advancesThe effect of intra-tympanic dexamethasone on the vestibular function in patients with recurrent vertigo.Repeated courses of intratympanic dexamethasone injection are effective for intractable Meniere's disease.Methylprednisolone versus Dexamethasone for Control of Vertigo in Patients with Definite Meniere's disease.Meniett device in meniere disease: Randomized, double-blind, placebo-controlled multicenter trial.Intratympanic corticosteroids in Ménière's disease: A mini-review.
P2860
Intratympanic dexamethasone as a symptomatic treatment for Ménière's disease.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Intratympanic dexamethasone as a symptomatic treatment for Ménière's disease.
@en
type
label
Intratympanic dexamethasone as a symptomatic treatment for Ménière's disease.
@en
prefLabel
Intratympanic dexamethasone as a symptomatic treatment for Ménière's disease.
@en
P2093
P1476
Intratympanic dexamethasone as a symptomatic treatment for Ménière's disease.
@en
P2093
David S Haynes
Elizabeth C Pearce
George B Wanna
Jennifer Best
Marc L Bennett
Mary Dietrich
Theodore R McRackan
P304
P356
10.1097/MAO.0000000000000500
P577
2014-10-01T00:00:00Z